206 related articles for article (PubMed ID: 23121989)
1. Do drug treatment variables predict cognitive performance in multidrug-treated opioid-dependent patients? A regression analysis study.
Rapeli P; Fabritius C; Kalska H; Alho H
Subst Abuse Treat Prev Policy; 2012 Nov; 7():45. PubMed ID: 23121989
[TBL] [Abstract][Full Text] [Related]
2. Cognitive functioning in opioid-dependent patients treated with buprenorphine, methadone, and other psychoactive medications: stability and correlates.
Rapeli P; Fabritius C; Kalska H; Alho H
BMC Clin Pharmacol; 2011 Aug; 11():13. PubMed ID: 21854644
[TBL] [Abstract][Full Text] [Related]
3. Methadone vs. buprenorphine/naloxone during early opioid substitution treatment: a naturalistic comparison of cognitive performance relative to healthy controls.
Rapeli P; Fabritius C; Alho H; Salaspuro M; Wahlbeck K; Kalska H
BMC Clin Pharmacol; 2007 Jun; 7():5. PubMed ID: 17565668
[TBL] [Abstract][Full Text] [Related]
4. Memory function in opioid-dependent patients treated with methadone or buprenorphine along with benzodiazepine: longitudinal change in comparison to healthy individuals.
Rapeli P; Fabritius C; Kalska H; Alho H
Subst Abuse Treat Prev Policy; 2009 Apr; 4():6. PubMed ID: 19374740
[TBL] [Abstract][Full Text] [Related]
5. High prevalence of constipation and reduced quality of life in opioid-dependent patients treated with opioid substitution treatments.
Lugoboni F; Mirijello A; Zamboni L; Faccini M; Casari R; Cossari A; Gasbarrini A; Addolorato G; On Behalf Of Gics
Expert Opin Pharmacother; 2016 Nov; 17(16):2135-2141. PubMed ID: 27603712
[TBL] [Abstract][Full Text] [Related]
6. Less impairment on one portion of a driving-relevant psychomotor battery in buprenorphine-maintained than in methadone-maintained patients: results of a randomized clinical trial.
Soyka M; Hock B; Kagerer S; Lehnert R; Limmer C; Kuefner H
J Clin Psychopharmacol; 2005 Oct; 25(5):490-3. PubMed ID: 16160628
[TBL] [Abstract][Full Text] [Related]
7. Supervised dosing with a long-acting opioid medication in the management of opioid dependence.
Saulle R; Vecchi S; Gowing L
Cochrane Database Syst Rev; 2017 Apr; 4(4):CD011983. PubMed ID: 28447766
[TBL] [Abstract][Full Text] [Related]
8. Non-prescribed use of methadone and buprenorphine prior to opioid substitution treatment: lifetime prevalence, motives, and drug sources among people with opioid dependence in five Swedish cities.
Johnson B; Richert T
Harm Reduct J; 2019 May; 16(1):31. PubMed ID: 31046774
[TBL] [Abstract][Full Text] [Related]
9. Constipation and other common symptoms reported by women and men in methadone and buprenorphine maintenance treatment.
Haber PS; Elsayed M; Espinoza D; Lintzeris N; Veillard AS; Hallinan R
Drug Alcohol Depend; 2017 Dec; 181():132-139. PubMed ID: 29054032
[TBL] [Abstract][Full Text] [Related]
10. Neuropsychological functioning of opiate-dependent patients: a nonrandomized comparison of patients preferring either buprenorphine or methadone maintenance treatment.
Loeber S; Kniest A; Diehl A; Mann K; Croissant B
Am J Drug Alcohol Abuse; 2008; 34(5):584-93. PubMed ID: 18720267
[TBL] [Abstract][Full Text] [Related]
11. Intravenous Misuse of Methadone, Buprenorphine and Buprenorphine-Naloxone in Patients Under Opioid Maintenance Treatment: A Cross-Sectional Multicentre Study.
Lugoboni F; Zamboni L; Cibin M; Tamburin S;
Eur Addict Res; 2019; 25(1):10-19. PubMed ID: 30625491
[TBL] [Abstract][Full Text] [Related]
12. The effect of bundling medication-assisted treatment for opioid addiction with mHealth: study protocol for a randomized clinical trial.
Gustafson DH; Landucci G; McTavish F; Kornfield R; Johnson RA; Mares ML; Westergaard RP; Quanbeck A; Alagoz E; Pe-Romashko K; Thomas C; Shah D
Trials; 2016 Dec; 17(1):592. PubMed ID: 27955689
[TBL] [Abstract][Full Text] [Related]
13. Mortality risk of opioid substitution therapy with methadone versus buprenorphine: a retrospective cohort study.
Kimber J; Larney S; Hickman M; Randall D; Degenhardt L
Lancet Psychiatry; 2015 Oct; 2(10):901-8. PubMed ID: 26384619
[TBL] [Abstract][Full Text] [Related]
14. Non-prescribed use of opioid substitution medication: Patterns and trends in sub-populations of opioid users in Germany.
Schulte B; Schmidt CS; Strada L; Götzke C; Hiller P; Fischer B; Reimer J
Int J Drug Policy; 2016 Mar; 29():57-65. PubMed ID: 26818083
[TBL] [Abstract][Full Text] [Related]
15. Delayed villous maturation in term placentas exposed to opioid maintenance therapy: a retrospective cohort study.
Serra AE; Lemon LS; Mokhtari NB; Parks WT; Catov JM; Venkataramanan R; Caritis SN
Am J Obstet Gynecol; 2017 Apr; 216(4):418.e1-418.e5. PubMed ID: 28024988
[TBL] [Abstract][Full Text] [Related]
16. "Should I stay or should I go?" Coming off methadone and buprenorphine treatment.
Winstock AR; Lintzeris N; Lea T
Int J Drug Policy; 2011 Jan; 22(1):77-81. PubMed ID: 20956077
[TBL] [Abstract][Full Text] [Related]
17. Neuropsychological performance of methadone-maintained opiate users.
Wang GY; Wouldes TA; Kydd R; Jensen M; Russell BR
J Psychopharmacol; 2014 Aug; 28(8):789-99. PubMed ID: 24920133
[TBL] [Abstract][Full Text] [Related]
18. Peripartum Anesthetic Management of the Opioid-tolerant or Buprenorphine/Suboxone-dependent Patient.
Pan A; Zakowski M
Clin Obstet Gynecol; 2017 Jun; 60(2):447-458. PubMed ID: 28426507
[TBL] [Abstract][Full Text] [Related]
19. Benzodiazepine Use in Opioid Maintenance Treatment Programme: Risks and Clinical Outcomes.
Oliveira C; Filipe R; Meira J; Sampaio L; Teixeira L; Rodrigues J; Nunes I; Tavares J
Acta Med Port; 2021 Mar; 34(3):209-216. PubMed ID: 33971116
[TBL] [Abstract][Full Text] [Related]
20. Dissatisfaction with opioid maintenance treatment partly explains reported side effects of medications.
Muller AE; Bjørnestad R; Clausen T
Drug Alcohol Depend; 2018 Jun; 187():22-28. PubMed ID: 29626742
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
